Novo Nordisk A/S: updates and filings

NVONYSEHealthcare · Pharmaceutical Preparations

Price

$37.82

November 20, 2026Market cap $168B

What Ploutos Investor adds for Novo Nordisk A/S

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 7 fiscal years, from 2019
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Feb 4, 2026 latest annual
  • Nov 16, 2026Current report (foreign company)
    Form6-K
  • Nov 9, 2026Current report (foreign company)
    Form6-K
  • Nov 5, 2026Current report (foreign company)
    Form6-K
  • Nov 4, 2026Current report (foreign company)
    Form6-K
  • Nov 3, 2026Current report (foreign company)
    Form6-K
  • Oct 26, 2026Current report (foreign company)
    Form6-K
  • Oct 19, 2026Current report (foreign company)
    Form6-K
  • Oct 13, 2026Current report (foreign company)
    Form6-K
  • Oct 6, 2026Current report (foreign company)
    Form6-K
  • Oct 5, 2026Current report (foreign company)
    Form6-K
  • Sep 28, 2026Current report (foreign company)
    Form6-K
  • Sep 21, 2026Current report (foreign company)
    Form6-K
  • Sep 17, 2026Current report (foreign company)
    Form6-K
  • Sep 15, 2026Current report (foreign company)
    Form6-K
  • Sep 9, 2026Current report (foreign company)
    Form6-K
  • Aug 31, 2026Current report (foreign company)
    Form6-K
  • Aug 24, 2026Current report (foreign company)
    Form6-K
  • Aug 18, 2026Current report (foreign company)
    Form6-K
  • Aug 10, 2026Current report (foreign company)
    Form6-K
  • Aug 10, 2026Current report (foreign company)
    Form6-K
  • Aug 4, 2026Current report (foreign company)
    Form6-K
  • Aug 4, 2026Current report (foreign company)
    Form6-K
  • Aug 4, 2026Current report (foreign company)
    Form6-K
  • Jul 31, 2026Current report (foreign company)
    Form6-K
  • Jul 27, 2026Current report (foreign company)
    Form6-K

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Jan 18, 2001.

The full analysis

What do Novo Nordisk A/S's filings show?

The filings are where every one of Novo Nordisk A/S's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.